Safety and Efficacy of MultiHance in Pediatric Patients

NCT00323310 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

92

Enrollment

INDUSTRY

Sponsor class

Stopped Adequate statistical power at 92 dosed pts to meet study objectives.

Conditions

Central Nervous System Diseases

Interventions

DRUG: gadobenate dimeglumine

Sponsor

Bracco Diagnostics, Inc